Max Healthcare Institute Limited

NSEI:MAXHEALTH Stock Report

Market Cap: ₹981.8b

Max Healthcare Institute Future Growth

Future criteria checks 5/6

Max Healthcare Institute is forecast to grow earnings and revenue by 33.8% and 27.4% per annum respectively. EPS is expected to grow by 34% per annum. Return on equity is forecast to be 17.3% in 3 years.

Key information

33.8%

Earnings growth rate

34.0%

EPS growth rate

Healthcare earnings growth28.0%
Revenue growth rate27.4%
Future return on equity17.3%
Analyst coverage

Good

Last updated17 Feb 2025

Recent future growth updates

Max Healthcare Institute Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 02
Max Healthcare Institute Limited Just Missed Earnings - But Analysts Have Updated Their Models

Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Nov 09
Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

May 25
Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

Recent updates

Max Healthcare Institute Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 02
Max Healthcare Institute Limited Just Missed Earnings - But Analysts Have Updated Their Models

Max Healthcare Institute (NSE:MAXHEALTH) Ticks All The Boxes When It Comes To Earnings Growth

Jan 13
Max Healthcare Institute (NSE:MAXHEALTH) Ticks All The Boxes When It Comes To Earnings Growth

We Think Max Healthcare Institute (NSE:MAXHEALTH) Can Stay On Top Of Its Debt

Nov 30
We Think Max Healthcare Institute (NSE:MAXHEALTH) Can Stay On Top Of Its Debt

Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Nov 09
Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Sep 14
Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Jul 18
Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark

Jun 21
Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark

Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

May 25
Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today

Apr 14
Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today

Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors

Mar 18
Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors

Earnings and Revenue Growth Forecasts

NSEI:MAXHEALTH - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2027128,87124,03114,788N/A21
3/31/2026106,72619,2389,357N/A22
3/31/202584,13414,485-3,429N/A21
12/31/202465,41610,084N/AN/AN/A
9/30/202460,08310,5902,64913,125N/A
6/30/202456,64010,538N/AN/AN/A
3/31/202454,06010,5763,35911,218N/A
12/31/202351,97610,570N/AN/AN/A
9/30/202350,0449,9017,14111,564N/A
6/30/202347,80711,708N/AN/AN/A
3/31/202345,62611,0359,48512,841N/A
12/31/202242,7999,763N/AN/AN/A
9/30/202241,1439,4373,8739,507N/A
6/30/202239,9766,310N/AN/AN/A
3/31/202239,3666,0511,8727,405N/A
12/31/202137,9785,510N/AN/AN/A
9/30/202136,1934,5161,4863,086N/A
6/30/202132,4863,236N/AN/AN/A
3/31/202125,080-1,375-61,179N/A
12/31/202027,772-1,177N/AN/AN/A
9/30/202022,487-2,1343,0243,911N/A
6/30/202014,849-2,681N/AN/AN/A
3/31/202010,590590-130771N/A
12/31/201910,081268N/AN/AN/A
9/30/201918,609720N/AN/AN/A
6/30/201917,719360N/AN/AN/A
3/31/201916,939-30-268890N/A
6/30/201817,053-704N/AN/AN/A
3/31/201817,303-302N/A822N/A
3/31/201716,085-14N/A1,561N/A
3/31/201614,343-180N/A7,225N/A
3/31/20157,896-381N/A387N/A
3/31/20149,445-646N/A732N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MAXHEALTH's forecast earnings growth (33.8% per year) is above the savings rate (6.7%).

Earnings vs Market: MAXHEALTH's earnings (33.8% per year) are forecast to grow faster than the Indian market (17.7% per year).

High Growth Earnings: MAXHEALTH's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MAXHEALTH's revenue (27.4% per year) is forecast to grow faster than the Indian market (10.6% per year).

High Growth Revenue: MAXHEALTH's revenue (27.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MAXHEALTH's Return on Equity is forecast to be low in 3 years time (17.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/22 21:32
End of Day Share Price 2025/02/21 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Max Healthcare Institute Limited is covered by 33 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nitin BhasinAmbit Capital
Prashant NairAmbit Capital
null nullAnand Rathi Shares and Stock Brokers Limited